MedTrace Logo

Pain and Chronic Pancreatitis - Clinical End Experimental Studies

NCT00755573 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2010-08-20

No results posted yet for this study

Summary

The aim of the study is to investigate the effect of pregabalin in pain resulting from chronic pancreatitis. The effect will be investigated by means of questionnaires concerning the daily experience of pain and the general quality of life. Furthermore the patients will be invited to participate in experimental testing with a multimodal pain model. The experimental testing will include stimulation of the skin, muscle and visceral tissue. The results from the experimental part of the study may help us to understand the mechanisms of action of pregabalin in this patient population.

Conditions

  • Chronic Pancreatitis

Interventions

DRUG

Pregabalin

Pregabalin 300 mg - 600 mg BID

DRUG

placebo

Regime as described for pregabalin

Sponsors & Collaborators

  • Radboud University Medical Center

    collaborator OTHER

  • Aalborg University Hospital

    lead OTHER

Principal Investigators

  • Asbjørn M Drewes, MD, PhD · Dapartment og Gastroenterology, Aalborg Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • Denmark
  • Netherlands

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00755573 on ClinicalTrials.gov